Filing Details
- Accession Number:
- 0001493152-24-028011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-16 15:39:00
- Reporting Period:
- 2024-01-02
- Accepted Time:
- 2024-07-16 15:39:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1812727 | Reliance Global Group Inc. | RELI | Insurance Agents, Brokers & Service (6411) | 463390293 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1953618 | Joel Markovits | C/O Reliance Global Group, Inc. 300 Blvd. Of The Americas, Suite 105 Lakewood NJ 08701 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-02 | 2,666 | $0.00 | 69,360 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-01-10 | 109 | $0.52 | 69,251 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-02-02 | 122 | $0.46 | 69,129 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-03-06 | 121 | $0.48 | 69,008 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-04-11 | 131 | $0.35 | 68,877 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-05-21 | 156 | $0.26 | 68,721 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-06-07 | 149 | $0.26 | 68,572 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2024-06-17 | 185,000 | $0.00 | 253,572 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-06-17 | 41,869 | $0.57 | 211,703 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-06-18 | 27,000 | $0.70 | 184,338 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the grant of shares of common stock approved by the compensation committee, comprised solely of independent directors, of the issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
- Share and dollar amounts do not reflect the issuer's 1-for-17 reverse stock split that was effectuated on July 1, 2024 (the "Reverse Split").
- Represents the payment of tax liability by delivering securities incident to the receipt of a previously reported stock grant, which was issued in accordance with Rule 16b-3. This transaction is exempt from Section 16(b) of the Exchange Act.
- Represents the payment of tax liability by delivering securities incident to the receipt of the January 2, 2024 grant of 2,666 shares of common stock reported on this Form 4, which was issued in accordance with Rule 16b-3. This transaction is exempt from Section 16(b) of the Exchange Act.
- Represents the payment of tax liability by delivering securities incident to the receipt of the June 17, 2024 grant of 185,000 shares of common stock reported on this Form 4, which was issued in accordance with Rule 16b-3. This transaction is exempt from Section 16(b) of the Exchange Act.
- The number of shares beneficially owned by the reporting person has been updated to account for certain prior rounding issues. After giving effect to the Reverse Split, the reporting person beneficially owned 10,844 shares of the issuer's common stock following the transactions reported on this Form 4.
Billionaire Hedge Funds
